{"id":"metafolin","rwe":[],"tags":[],"safety":{"commonSideEffects":[{"effect":"Allergic sensitization","drugRate":"reported","severity":"unknown"},{"effect":"Fatigue","drugRate":"reported","severity":"unknown"}],"contraindications":["Acute nephropathy","Adrenal cortical hypofunction","Asthma","Bed-ridden","Body fluid retention","Breast lump","Carcinoma of female breast","Cardiovascular event risk","Cerebrovascular accident","Chloasma","Chorea","Chronic heart failure","Deep venous thrombosis","Dementia","Depressive disorder","Diabetes mellitus","Diplopia","Disease of liver","Disorder of coronary artery","Disorder of gallbladder","Endometrial carcinoma","Endometriosis","Epilepsy","Estrogen receptor positive tumor","Family history of malignant neoplasm of breast","Functional visual loss","Hepatic porphyria","Humoral hypercalcemia of malignancy","Hypercholesterolemia","Hyperkalemia","Hyperlipidemia","Hyperlipoproteinemia","Hypertensive disorder","Hypertensive urgency","Hypertriglyceridemia","Hypocalcemia","Hypothyroidism","Intermenstrual bleeding - irregular","Kidney disease","Malignant tumor of ovary","Mammography abnormal","Migraine","Myocardial infarction","Obesity","Optic disc edema","Porphyria","Pregnancy, function","Pulmonary thromboembolism","Retinal hemorrhage","Seizure disorder","Smokes tobacco daily","Systemic lupus erythematosus","Thromboembolic disorder","Thrombophilia","Thrombophlebitis","Thrombosis of retinal vein","Uterine leiomyoma"]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T17:29:28.652804","offLabel":[],"timeline":[],"_dailymed":{"setId":"a5bd85b5-f0c2-4afc-9d12-cc76d7ebec59","title":"TRI-VITAMIN DROPS WITH FLUORIDE (VITAMIN A (AS PALMITATE), VITAMIN D (AS CHOLECALCIFEROL), FOLATE (FROM METAFOLIN), FLUORIDE (AS SODIUM FLUORIDE)) SUSPENSION/ DROPS [NEOS THERAPEUTICS, LP]"},"ecosystem":[],"mechanism":{"target":"Thymidylate synthase","modality":"Small Molecule"},"_scrapedAt":"2026-03-28T06:13:15.386Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Acne vulgaris","diseaseId":"acne-vulgaris","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Contraception","diseaseId":"contraception","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Premenstrual dysphoric disorder","diseaseId":"premenstrual-dysphoric-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"_fixedFields":["sideEffects","modality→Small Molecule"],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07461649","phase":"NA","title":"Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Credit Pharmaceutical Co., Ltd.","startDate":"2026-03-15","conditions":"Bioavailability and Pharmacokinetics","enrollment":32},{"nctId":"NCT03059173","phase":"PHASE3","title":"Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2023-09-12","conditions":"Polycystic Ovary Syndrome, Reproductive Medicine","enrollment":276},{"nctId":"NCT04586348","phase":"PHASE4","title":"Prenatal Iodine Supplementation and Early Childhood Neurodevelopment","status":"ACTIVE_NOT_RECRUITING","sponsor":"South Australian Health and Medical Research Institute","startDate":"2021-01-18","conditions":"Pregnancy Related, Neurodevelopmental Disorders, Nutrition Disorder, Fetal","enrollment":794},{"nctId":"NCT01687127","phase":"NA","title":"Impact of High-dose Folic Acid Supplementation on Pathways Linked to DNA Formation","status":"NOT_YET_RECRUITING","sponsor":"University of British Columbia","startDate":"2024-01-01","conditions":"One-carbon Metabolism in Healthy Individuals","enrollment":25},{"nctId":"NCT04022135","phase":"NA","title":"Natural Folate vs. Synthetic Folic Acid in Pregnancy","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2019-09-16","conditions":"Pregnancy","enrollment":60},{"nctId":"NCT01266408","phase":"","title":"INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)","status":"COMPLETED","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2010-11-22","conditions":"Contraception","enrollment":82921},{"nctId":"NCT01360996","phase":"PHASE4","title":"Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism","status":"COMPLETED","sponsor":"Woman's","startDate":"2011-08","conditions":"Polycystic Ovary Syndrome","enrollment":64},{"nctId":"NCT00941057","phase":"PHASE1","title":"Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-09","conditions":"Pharmacology, Clinical","enrollment":43},{"nctId":"NCT01902264","phase":"PHASE3","title":"Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-08","conditions":"Contraception","enrollment":34},{"nctId":"NCT00372645","phase":"NA","title":"Increasing Folate Status of a General Population(FOLSUPP STUDY)","status":"COMPLETED","sponsor":"Quadram Institute Bioscience","startDate":"2005-05","conditions":"Healthy","enrollment":180},{"nctId":"NCT00400387","phase":"PHASE3","title":"Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss","status":"COMPLETED","sponsor":"University of Jena","startDate":"2006-11","conditions":"Abortion, Habitual","enrollment":449},{"nctId":"NCT01331655","phase":"PHASE3","title":"Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America","status":"WITHDRAWN","sponsor":"Bayer","startDate":"2013-04","conditions":"Contraception","enrollment":""},{"nctId":"NCT00468481","phase":"PHASE3","title":"Efficacy and Safety Study for an Oral Contraceptive Containing Folate","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-04","conditions":"Neural Tube Defects, Contraception, Oral Contraceptives (OC)","enrollment":385},{"nctId":"NCT01031355","phase":"PHASE1","title":"Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-12","conditions":"Contraception, Ovulation Inhibition","enrollment":42},{"nctId":"NCT01258660","phase":"PHASE1","title":"Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-12","conditions":"Contraception","enrollment":172},{"nctId":"NCT01253174","phase":"PHASE1","title":"Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and Yasmin + Levomefolate Calcium (Metafolin)","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-08","conditions":"Contraception","enrollment":48},{"nctId":"NCT01253187","phase":"PHASE1","title":"Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-10","conditions":"Contraception","enrollment":44},{"nctId":"NCT01370954","phase":"","title":"NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)","status":"COMPLETED","sponsor":"Pamlab, Inc.","startDate":"2011-05","conditions":"Early Memory Loss, Mild Cognitive Impairment, Alzheimer's Disease","enrollment":204},{"nctId":"NCT00348933","phase":"NA","title":"Dietary Supplements for the Treatment of Angelman Syndrome","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2006-07","conditions":"Angelman Syndrome, Nervous System Diseases","enrollment":90},{"nctId":"NCT01584050","phase":"NA","title":"Relative Bioavailability of Folic Acid and L-5-Methlytetrahydrofolate","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2012-05","conditions":"Vitamin B12 Deficiency","enrollment":150}],"_emaApprovals":[],"_faersSignals":[{"count":7,"reaction":"CRYPTORCHISM"},{"count":6,"reaction":"SMALL FOR DATES BABY"},{"count":3,"reaction":"FOETAL EXPOSURE DURING PREGNANCY"},{"count":3,"reaction":"MATERNAL EXPOSURE DURING PREGNANCY"},{"count":2,"reaction":"ANXIETY"},{"count":2,"reaction":"ARTHRALGIA"},{"count":2,"reaction":"ASTHENIA"},{"count":2,"reaction":"BLOOD GLUCOSE INCREASED"},{"count":2,"reaction":"BLOOD THYROID STIMULATING HORMONE DECREASED"},{"count":2,"reaction":"BLUNTED AFFECT"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":15,"therapeuticAreas":["Dermatology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Metafolin","genericName":"Metafolin","companyName":"University of California, San Diego","companyId":"university-of-california-san-diego","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}